clarithromycin has been researched along with tacrolimus in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (18.52) | 18.2507 |
| 2000's | 9 (33.33) | 29.6817 |
| 2010's | 9 (33.33) | 24.3611 |
| 2020's | 4 (14.81) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, T; Hui, CS; Kitaichi, K; Miyamoto, KI; Sakai, M; Takagi, K; Wang, L; Yokogawa, K | 1 |
| Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fritschka, E; Philipp, T; Wagner, K; Wolter, K | 1 |
| Iwamoto, K; Morikawa, K; Morikawa, S; Oseko, F | 1 |
| Demetris, AJ; Gritsch, A; Jordan, M; Katari, SR; Magnone, M; McCauley, J; Randhawa, PS; Scantlebury, V; Shapiro, R; Starzl, T; Vivas, C | 1 |
| Ito, K; Kawasaki, S; Koyama, T; Otoshi, T; Takami, K; Takizawa, H | 1 |
| Alvarez, ML; Ballester, B; Errasti, P; García, I; García, N; Gómez, G; Lavilla, FJ; Purroy, A | 1 |
| Ashihara, E; Fujita, N; Hatsuse, M; Inaba, T; Nakagawa, M; Noda, Y; Ochiai, N; Okano, A; Shimazaki, C; Takahashi, R | 1 |
| Abella, EM; Chandrasekar, PH; Ibrahim, RB | 1 |
| Bhaloo, S; Prasad, GV | 1 |
| Kunicki, PK; Sobieszczańska-Małek, M | 1 |
| Baptista, J; Caldas, LL; Ferreira, A; Fidalgo, A; Rocha Paris, F | 1 |
| Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Nakamura, S; Takazono, T; Yanagihara, K | 1 |
| Katayama, M; Okamura, Y; Shimamura, S; Ushio, T; Uzuka, Y | 1 |
| Kataoka, H; Mukai, M; Ohe, M | 1 |
| Baluch, A; Pasikhova, Y; Snyder, M | 1 |
| Sunaga, T; Yonezawa, R | 1 |
| Hirai, T; Ikejiri, M; Ino, K; Iwamoto, T; Tawara, I | 1 |
| Hu, W; Wen, J; Xiao, YW; Zhao, M | 1 |
| Hayashi, N; Hirama, T; Kikuchi, M; Kumondai, M; Maekawa, M; Mano, N; Mizuguchi, A; Okada, Y; Sato, T; Sato, Y; Ui, M | 1 |
2 review(s) available for clarithromycin and tacrolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Clarithromycin; Combined Modality Therapy; Cyclosporine; Debridement; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotrexate; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Skin Ulcer; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2001 |
25 other study(ies) available for clarithromycin and tacrolimus
| Article | Year |
|---|---|
Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cell Membrane; Cell Survival; Cyclosporine; Drug Resistance, Neoplasm; Immunosuppressive Agents; Leukemia P388; Macrolides; Mice; Neoplasm Transplantation; Tumor Cells, Cultured; Verapamil; Vinblastine | 2000 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Interaction between FK 506 and clarithromycin in a renal transplant patient.
Topics: Clarithromycin; Drug Interactions; Female; Humans; Kidney Transplantation; Middle Aged; Tacrolimus | 1994 |
Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro.
Topics: Adjuvants, Immunologic; Anti-Bacterial Agents; Cell Division; Cell Survival; Clarithromycin; Cyclosporine; Humans; Interleukin-2; Josamycin; Kinetics; Leucomycins; Leukocytes, Mononuclear; Receptors, Interleukin-2; Stimulation, Chemical; T-Lymphocytes; Tacrolimus | 1994 |
Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Biopsy, Needle; Clarithromycin; Creatinine; Diltiazem; Drug Interactions; Female; Humans; Hyperglycemia; Hyperkalemia; Hypertension; Immunosuppressive Agents; Infusions, Intravenous; Itraconazole; Kidney; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Time Factors; Transplantation, Homologous; Tremor; Ultrasonography; Vasodilator Agents | 1997 |
[Effects of various drugs on IL-8 production by eosinophils collected from patients with allergic inflammation].
Topics: Anti-Bacterial Agents; Asthma; Clarithromycin; Eosinophils; Erythromycin; Fosfomycin; Humans; Hypersensitivity; Immunosuppressive Agents; In Vitro Techniques; Interleukin-8; Josamycin; Tacrolimus | 1998 |
Acute tacrolimus nephrotoxicity in renal transplant patients treated with clarithromycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Azathioprine; Clarithromycin; Creatinine; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Prednisone; Tacrolimus | 1999 |
Tacrolimus-clarithromycin interaction in a patient receiving bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Clarithromycin; Drug Interactions; Humans; Male; Tacrolimus | 2002 |
Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors: a case report.
Topics: Adult; Clarithromycin; Creatinine; Cytochrome P-450 Enzyme Inhibitors; Diltiazem; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Rifampin; Tacrolimus | 2003 |
Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient.
Topics: Area Under Curve; Azathioprine; Clarithromycin; Drug Administration Schedule; Drug Interactions; Duodenitis; Half-Life; Heart Transplantation; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Tacrolimus | 2005 |
Topical tacrolimus in Hailey-Hailey disease.
Topics: Adjuvants, Immunologic; Administration, Topical; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Middle Aged; Pemphigus, Benign Familial; Tacrolimus | 2005 |
Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report.
Topics: Adalimumab; Administration, Oral; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Clarithromycin; Ethambutol; Glucocorticoids; Humans; Male; Mycobacterium; Mycobacterium Infections; Polychondritis, Relapsing; Rifampin; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Preliminary study of interaction of clarithromycin with tacrolimus in cats.
Topics: Animals; Biological Availability; Cat Diseases; Cats; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Immunosuppression Therapy; Kidney Failure, Chronic; Kidney Transplantation; Male; Tacrolimus | 2014 |
A case of lupus nephritis treated with clarithromycin, tacrolimus, and glucocorticoids.
Topics: Adult; Clarithromycin; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Lupus Nephritis; Tacrolimus | 2016 |
Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient.
Topics: Anti-Bacterial Agents; Biopsy; Cellulitis; Ciprofloxacin; Clarithromycin; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lower Extremity; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Rifabutin; Tacrolimus; Unrelated Donors | 2017 |
Signal of safety due to adverse drug reactions induced by tacrolimus with or without azithromycin.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug-Related Side Effects and Adverse Reactions; Humans; Tacrolimus | 2022 |
Dual Inhibition of CYP3A4 by Voriconazole and Clarithromycin Influences Tacrolimus Pharmacokinetics: Case Series Study.
Topics: Clarithromycin; Cytochrome P-450 CYP3A; Genotype; Immunosuppressive Agents; Tacrolimus; Voriconazole | 2022 |
Effects of clarithromycin on the pharmacokinetics of tacrolimus and expression of CYP3A4 and P-glycoprotein in rats.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cytochrome P-450 CYP3A; Rats; Tacrolimus | 2023 |
Therapeutic Drug Monitoring of Blood Sirolimus and Tacrolimus Concentrations for Polypharmacy Management in a Lymphangioleiomyomatosis Patient Taking Two Cytochrome P450 3A Inhibitors.
Topics: Clarithromycin; Cytochrome P-450 CYP3A; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Itraconazole; Lymphangioleiomyomatosis; Middle Aged; Mycophenolic Acid; Polypharmacy; Prednisolone; Sirolimus; Tacrolimus | 2023 |